ENDO: Glycemic Control Good for Regular Human Insulin With V-Go

WEDNESDAY, April 1, 2020 -- For patients with type 2 diabetes (T2D), glycemic control is similar with use of regular human insulin (RHI) and rapid-acting insulin (RAI) when delivered with a wearable insulin delivery device, V-Go, according to a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news